CSIMarket
 



Landos Biopharma Inc   (LABP)
Other Ticker:  
 



Landos Biopharma Inc 's Debt Coverage ratios

LABP's Debt and Ebitda growth


LABP Debt Coverage (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Total Debt Change - - - - -
Y / Y Ebitda Change - - 567.59 % - -
Debt Coverage (TTM) - - - - -
Total Ranking # # # # #
Seq. Total Debt Change - - - - -
Seq. Ebitda Change - - - - -





Debt Coverage Ratio second quarter of 2023 Comment
Company did not have debt in the second quarter of 2023.

Within Healthcare sector Landos Biopharma Inc achieved highest debt coverage ratio in the second quarter of 2023. While debt coverage ratio ranking remained unchanged in the Q2 2023 compared to the first quarter 2023 at no. .
Debt Coverage Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Debt Coverage Ratio Statistics
High Average Low
0 0 0
 



Financial Statements
Landos Biopharma Inc 's Total Debt $ 0 Millions Visit LABP's Balance sheet
Landos Biopharma Inc 's Ebitda $ -3 Millions Visit LABP's Income Statement
Where are LABP's Sales coming from? Visit LABP's Sales by Geography




Companies with similar Debt Coverage Jun 30 2023, within Healthcare Sector Debt Coverage
Date modified: 2023-08-11T05:34:24+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com